Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-21

Clinical Trial Update: Effects of Low Dose Naltrexone in Fibromyalgia [NA]

View source ↗

Summary

Stanford-sponsored trial evaluated the effects of low-dose naltrexone in fibromyalgia. Results were posted on 2015-10-21 after the study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naltrexone (low-dose) (naltrexone)

Snippet

Sponsor: Stanford University | Conditions: Fibromyalgia, Persian Gulf Syndrome | NA | Status: COMPLETED | Results posted: 2015-10-21